State University of New York Downstate Medical Center and Kings County Hospital Center, VA Medical Center, Brooklyn, NY, USA.
Am J Nephrol. 2009;30(3):261-7. doi: 10.1159/000223527. Epub 2009 Jun 4.
BACKGROUND/AIMS: The prevalence of diabetic kidney disease (DKD) and risk of progression to end-stage renal disease is higher in African-Americans as compared to Caucasians. Whether the higher rate of estimated glomerular filtration rate (eGFR) decline in African-Americans is mediated by poor glycemic control is unclear.
We conducted a prospective study of 183 (African-American, n = 95; Caucasian, n = 88, mean age 66 +/- 10 vs. 70 +/- 11 years) patients with a diagnosis of DKD followed over a period of 12 months. eGFR (ml/min/1.73 m(2)) was calculated by MDRD formula and grouped into stage 1-2 (> or =60 ml/min), stage 3 (30-60 ml/min) and stage 4 (<30 ml/min). In addition, glycosylated hemoglobin A1C (HbA1c) was categorized into tertiles (<7, 7-8 and >8%) at each time point.
There were no significant differences in eGFR at any time point between African-American and Caucasian in any stage of CKD during this period. There were also no significant differences in eGFR at any time point in each category of HbA1c.
Our data indicate that there were no ethnic differences in the rate of progression of DKD under equivalent glycemic control. Further research is needed to explore the mechanisms associated with higher prevalence and rapid progression of CKD in African-Americans compared to Caucasians.
背景/目的:与白种人相比,非裔美国人的糖尿病肾病(DKD)患病率更高,进展为终末期肾病的风险也更高。非裔美国人估算肾小球滤过率(eGFR)下降速度更快是否是由于血糖控制不佳导致的,目前尚不清楚。
我们对 183 例 DKD 患者进行了前瞻性研究(非裔美国人,n=95;白种人,n=88,平均年龄 66±10 岁 vs. 70±11 岁),这些患者在 12 个月的随访期间进行了 eGFR(ml/min/1.73m2)评估。采用 MDRD 公式计算 eGFR,并将其分为 1-2 期(>60ml/min)、3 期(30-60ml/min)和 4 期(<30ml/min)。此外,在每个时间点,根据糖化血红蛋白 A1C(HbA1c)将其分为三部分(<7、7-8 和>8%)。
在这段时间内,在任何 CKD 阶段,非裔美国人和白种人之间的任何时间点的 eGFR 均无显著差异。在每个 HbA1c 类别中,任何时间点的 eGFR 也无显著差异。
我们的数据表明,在血糖控制相当的情况下,非裔美国人和白种人 DKD 的进展速度没有种族差异。需要进一步研究以探讨与非裔美国人相比,白种人 CKD 患病率更高和进展更快的相关机制。